Skip navigation

Search results for hearings

Showing 601 to 615 of 845 results

Operating department practitioners

Professional bodies typically promote the profession, represent their members and provide curriculum frameworks, training and CPD.

Speech and language therapists

Professional bodies typically promote the profession, represent their members and provide curriculum frameworks, training and CPD.

Registrants and representative organisations

Communicating with our registrants is essential to the work that we do. It is important that registrants are kept up to date with developments that affect their professional registration

Radiographers

The standards of proficiency that radiographer must meet in order to join, and remain on, the HCPC Register. 

Dietitians

Professional bodies typically promote the profession, represent their members and provide curriculum frameworks, training and CPD.

Physiotherapists

Professional bodies typically promote the profession, represent their members and provide curriculum frameworks, training and CPD.

Employer newsletter

Subscribe for updates on developments that affect your employees and help you to help them meet their regulatory obligations – and yours

HCPC publishes retention rates of first time registrants

This report contains the HCPC’s first scientific assessment of the time new HCPC registrants stayed registered for

Prosthetists / orthotists

Professional bodies typically promote the profession, represent their members and provide curriculum frameworks, training and CPD.

Orthoptists

The standards of proficiency that orthoptists must meet in order to join, and remain on, the HCPC Register. 

How to activate your online account

Guidance on how to activate your account to enable you to renew online.

Consultation on standards of conduct, performance and ethics

We are seeking feedback on proposed changes to the Standards of conduct, performance and ethics for each of the 15 professions we regulate. 

Reclassification of gabapentin and pregabalin

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)